Biotech · Private company
Amarin Pharma Inc.
Track this companyFree. Adds Amarin Pharma Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AMR101Phase 3 · Cardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- AMR101 (ethyl icosapentate) - 2 g/dayPhase 3 · HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- AMR101 (ethyl icosapentate) - 4 g/dayPhase 3 · HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- Statin therapyPhase 3 · Cardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on StatinPHASE3 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01492361 · fetched Nov 12, 2026
- Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)PHASE3 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01047501 · fetched Nov 12, 2026
- Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dLPHASE3 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01047683 · fetched Nov 12, 2026